tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market
Want to see BOLT full AI Analyst Report?

Bolt Biotherapeutics (BOLT) Ownership - Who Owns Bolt Biotherapeutics?

247 Followers

Bolt Biotherapeutics (BOLT) Ownership Overview

2.28%3.97%23.96%0.37%69.42%
23.96% Other Institutional Investors
0.37% ETFs
69.42% Public Companies and
Individual Investors
The ownership structure of Bolt Biotherapeutics (BOLT) stock is a mix of institutional, retail, and individual investors. Approximately 28.30% of the company’s stock is owned by Institutional Investors, 2.28% is owned by Insiders, and 69.42% is owned by Public Companies and Individual Investors.
The ownership structure of Bolt Biotherapeutics (BOLT) stock is a mix of institutional, retail, and individual investors. Approximately 27.93% of the company’s stock is owned by Institutional Investors, 2.28% is owned by Insiders, and 0.37% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
50,695Institution2.64%232,690
38,918Insider2.03%178,634
15,826Institution0.82%72,641
7,060Institution0.37%32,405
7,060Institution0.37%32,405
2,700Institution0.14%12,393
2,313Insider0.12%10,617
1,415Insider0.07%6,495
1,200Insider0.06%5,508

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
50,695Institution2.64%232,690
15,826Institution0.82%72,641
7,060Institution0.37%32,405
2,700Institution0.14%12,393

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,060Institution0.37%37,065

FAQ

Who Owns Bolt Biotherapeutics (BOLT)?
According to the latest TipRanks data, approximately 23.96% of the company's stock is held by institutional investors, 2.28% is held by insiders, and 69.42% is held by retail investors.
    What percentage of Bolt Biotherapeutics (BOLT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 23.96% of Bolt Biotherapeutics (BOLT) stock is held by institutional investors.
      What percentage of Bolt Biotherapeutics (BOLT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 69.42% of Bolt Biotherapeutics (BOLT) stock is held by retail investors.
        Who owns the most shares of Bolt Biotherapeutics (BOLT)?
        Fidelity Commonwealth Trust II owns the most shares of Bolt Biotherapeutics (BOLT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.